Enhancing Safety & Advancing QA
FRIDAY, 16 February & SATURDAY, 17 FEBRUARY, 2024
The 14th installment of QADS returns in 2024, with a new European destination —Lisbon, Portugal.
We welcome you to this premier educational event focused exclusively on strategies for continuous improvements in Quality and Patient Safety in Radiation Therapy. Over two days, attendees will learn best practices and clinical insights from colleagues practicing worldwide, while earning continuing education credits
See below for the prior QADS agenda. Stay tuned for the 2024 program.
Call for Speakers
As we build the symposium program, we are seeking speakers with unique and noteworthy insights. Submit a speaker proposal to share your knowledge.Topics should fall under one of these session themes:
- Safety and Quality in Radiation Therapy
- In-vivo / Transit dosimetry
- Automation and Integration in planning and QA
- SRS/SBRT QA and Small Field Dosimetry
- Advances in Dosimetry and QA solutions
- New treatment technologies and QA
Friday, April 8, 2022
8:00
2022 Program Introduction
Jie Shi, Ph.D., Sun Nuclear, Melbourne, FL
8:15
Cybersecurity Issues in RT and Solutions
Mike Kijewski, M.S., MedCrypt, San Diego, CA
8:45
Fault Recovery in Radiation Therapy - TG-314
Steven Sutlief, Ph.D., Banner MD Anderson Cancer Center, Gilbert, AZ
9:15
Incident Learning in Challenging Times - A Physician's Perspective
Bhisham Chera, M.D., Medical University of South Carolina, Charleston, SC
9:45
Simulated Error Training for the Physics Plan Review
Jacqueline T. Faught, Ph.D., AAPM Working Group on Prevention of Errors on Radiation Oncology, Memphis, TN
10:15
BREAK
10:30
Medical Physics 3.0 and Imaging QA
Ehsan Samei, Ph.D., AAPM President Elect, Duke University Medical Center, Durham, NC
11:00
Understand Radiation Oncology Alternative Payment Model with Monte Carlo Simulations
Alex Price, M.S., Washington University School of Medicine, St. Louis, MO
11:30
Panel Discussion
Moderated by Bill Simon, M.S., Sun Nuclear, Melbourne, FL
12:15
LUNCH
1:15
Comparison of Vendor-Dependent versus Commercially-Available, Independent LINAC QA
Cassandra Stambaugh, Ph.D., Tufts Medical Center, Boston, MA
1:45
Clinical Experience of a Comprehensive and Automated Machine QA Platform
David Morris, M.Sc., Clatterbridge Cancer Center, Liverpool, UK
2:15
Evaluating Clinical Workflow Changes Using Transit In Vivo Dosimetry
Evy Bossuyt, M.Sc., Iridium Netwerk, Wilrijk, Belgium
2:45
In Vivo Dosimetry for VMAT TBI Patients
David Barbee, Ph.D., NYU Langone Medical Center, New York, NY
3:15
BREAK
3:45
Point/Counterpoint: Pretreatment Patient-Specific Measurement Should Be Replaced with In Vivo Solutions - Part I
Moyed Miften, Ph.D., University of Colorado School of Medicine, Aurora, CO
4:15
Point/Counterpoint: Pretreatment Patient-Specific Measurement Should Be Replaced with In Vivo Solutions - Part II
Jean Moran, Ph.D., Memorial Sloan Kettering Cancer Center, New York, NY
4:45
Panel Discussion
Moderated by Steven Sutlief, Ph.D., Banner MD Anderson Cancer Center, Gilbert, AZ
5:15
Conclusion of Day One
6:00
NETWORKING RECEPTION
Saturday, April 9, 2022
8:15
Safety and QA of BGRT Using the RefleXion
Bin Cai, Ph.D., UT Southwest Medical Center, Dallas, TX
8:45
Unlocking a Closed System: Dosimetric Commissioning of Halcyon in a Multivendor Environment
Vladimir Feygelman, Ph.D., Moffit Cancer Center, Tampa, FL
9:00
Errors in Generating Synthetic CTs for Use in Adaptive Radiation Therapy
Deon Dick, Ph.D., Jaeger Corporation, Omaha, NE
9:15
Evaluation of Dosimetry Tools for UHDR Flash Radiotherapy
Mahbubur Rahman, Ph.D., Dartmouth College, West Lebanon, NH
9:45
BREAK
10:00
Patient-Specific QA for Small Target Treatments Using Spatially Fractionated Radiotherapy
Maria Carmen Banos-Capilla, Ph.D., Hospital
Vithas Consuelo, Valencia, Spain
10:30
Is AI Prediction Ready for Measurement-Based Patient-Specific QA?
Justus Adamson, Ph.D., Duke University, Durham, NC
11:00
Clinical Implementation of a MRgRT Quality Management Program
Jinzhong Yang, Ph.D., MD Anderson Cancer Center, Houston, TX
11:30
Panel Discussion
Moderated by Greg Robinson, M.S., CMD, RTT, Sun Nuclear, Melbourne, FL
12:00
LUNCH
1:00
Commissioning and QA of HyperArc/Edge
Richard Popple, Ph.D., University of Alabama at Birmingham, Birmingham, AL
1:30
CAVMAT: a Robust Single-Isocenter-Multiple-Target SRS Technique
Edward T. Cullom, M.S., Duke University, Durham, NC
2:00
An Overview of Hypofractionated Treatment Effects in the Clinic (HyTEC)
Issam EI Naqa, Ph.D., Moffit Cancer Center, Tampa, FL
2:30
Improving Dosimetry Data Collection for SRS/SBRT Commissioning
Jason Tracy, M.S., DABR, RT(T), Sun Nuclear, Melbourne, FL
3:00
BREAK
3:30
Evaluation of a Diode Array as an Alternative to Film-Based Methods for CyberKnife Machine QA
Pedro Cardoso, M.Sc., Hospital Vila Nova Star, Brazil
4:00
Advances and Challenges in the Treatment of Multiple Brain Metastases
Angelica Perez-Andujar, Ph.D., Memorial Sloan Kettering Cancer Center, West Harrison, NY
4:30
Program Conclusion
Starts Here™
Sun Nuclear does a great job selecting interesting and well-balanced topics for QADS.
ENDORSED BY AAPM
AAPM does not endorse the product in question: rather, it endorsed the educational component of the program.
